Clinical Trial Update: Study of JK06 in Patients With Unresectable Locally Advanced or Metastatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Salubris Biotherapeutics is conducting a Phase 1/2 study of JK06 for solid tumors, with recruitment ongoing for unresectable locally advanced or metastatic canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• JK06

Snippet

Sponsor: Salubris Biotherapeutics Inc | Conditions: Solid Tumor | Phase 1, Phase 2 | Status: RECRUITING